synthetic genomics Twist Bioscience Q2 Revenues Grow 62 Percent The synthetic DNA manufacturer missed the consensus Wall Street estimate for loss per share but beat analysts' estimate on the top line. Molecular Assemblies Extends Series A Financing Round by $11.8M The enzymatic DNA synthesis company added money from new and existing investors to a 2019 $12.2 million Series A round led by iSelect Fund. Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector. DNA Script Exclusively Licenses Modified DNA Printing Technology From Baseclick The Paris-based company plans to use the nucleic acid modification technology to synthesize qPCR probes for use in diagnostics, among other biomolecules. Twist Bioscience Reveals MRD Testing Applications, Regeneron Genotyping Project Premium In addition to discussing Twist's liquid biopsy, NGS-based genotyping and SARS-CoV-2 NGS panel, CEO Emily Leproust touted efforts on DNA data storage. Feb 4, 2021 Twist Bioscience Fiscal Q1 Revenues Grow 64 Percent; JP Morgan Downgrades to Underweight Dec 16, 2020 Sherlock Biosciences Receives $5M Gates Foundation Grant for COVID-19 Self-Test Dec 3, 2020 Twist Bioscience Prices Upsized $300M Public Offering Dec 2, 2020 Twist Bioscience Proposes $250M Public Offering Nov 23, 2020 Twist Bioscience Plots Continued Growth With NGS Product Push Into Ag-Bio, Cancer Dx Premium Aug 11, 2020 JP Morgan, Cowen, William Blair Initiate Coverage of Berkeley Lights Aug 6, 2020 Twist Bioscience Q3 Revenues Grow 56 Percent Jun 4, 2020 Twist Bioscience Prices $100M Stock Offering May 21, 2020 Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab Premium May 20, 2020 Omics-Driven Drug Discovery Firm Octant Raises $30M in Series A Financing Round May 7, 2020 Twist Bioscience Q2 Revenues Increase 42 Percent May 4, 2020 Researchers Rapidly Reconstruct SARS-CoV-2 Virus Using Synthetic Genomics Feb 7, 2020 With Agilent Litigation Gone, Twist Bioscience Sees Long-Term Growth in Biopharma, DNA Data Storage Premium Feb 6, 2020 Twist Bioscience Shares Soar on Speculation of Lawsuit Settlement With Agilent Jan 7, 2020 Genome Editors Begin Lining Up for Inscripta's Onyx Platform Premium Dec 12, 2019 Twist Bioscience Teases Products for Liquid Biopsy Market, Biopharma Collaborations Premium Dec 11, 2019 Twist Bioscience Fiscal Q4 Revenues Increase 87 Percent Oct 31, 2019 Sherlock Biosciences Aims to Create Dx Tool for 'Where Testing Should be Done, But Isn't' Premium Oct 10, 2019 Omics Tools Firms See Opportunities in Burgeoning Synthetic Biology Industry Premium Oct 2, 2019 Molecular Assemblies Raising Cash, Awareness for Enzymatic DNA Synthesis Premium Load More Breaking News JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Top Five Articles on GenomeWeb Last Week: Danaher, Becton Dickinson, 23andMe, and More Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.